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Background: The aim of this study was to investigate long-term risk of type 2 diabetes (T2D) following a diagnosis
of gestational diabetes and to identify factors that were associated with increased risk of T2D.
Methods: An observational cohort design was used, following up all women diagnosed with gestational diabetes
mellitus (GDM) attending a Diabetes Antenatal Clinic in the Dundee and Angus region of Scotland between 1994
and 2004 for a subsequent diagnosis of T2D, as recorded on SCI-DC (a comprehensive diabetes clinical information
system).
Results: There were 164 women in the study who were followed up until 2012. One quarter developed T2D after a
pregnancy with GDM in a mean time period of around eight years. Factors associated with a higher risk of developing
T2D after GDM were increased weight during pregnancy, use of insulin during pregnancy, higher glycated
haemoglobin (HbA1c) levels at diagnosis of GDM, and fasting blood glucose.
Conclusions: These findings suggest there is a viable time window to prevent progression from GDM to T2D and
highlights those women who are at the greatest risk and should therefore be prioritised for preventative intervention.
Keywords: Gestational diabetes, Type 2 diabetes, Follow-up, United KingdomBackground
Gestational diabetes mellitus (GDM) is defined as glu-
cose intolerance that begins or is first detected during
pregnancy. GDM can have health consequences for the
mother and baby both in the short and longer term. Al-
though normal glucose regulation usually returns shortly
after delivery, women diagnosed with GDM have at least
a seven fold increased risk of developing Type 2 diabetes
(T2D) in the future [1]. In Europe, GDM affects between
2-6% of pregnancies but research has shown that the in-
cidence of GDM has been rising [2,3].
T2D is a growing public health concern associated
with a number of serious health complications that re-
duce both the life-expectancy and quality of life of suf-
ferers [4,5]. There is good evidence to suggest that
lifestyle interventions targeted at those at high risk of
T2D, such as those with pre-diabetes, can prevent or at* Correspondence: c.e.eades@stir.ac.uk
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unless otherwise stated.least delay the onset of T2D [6]. A diagnosis of GDM
therefore represents a window of opportunity for pre-
ventative intervention. However, there has been little re-
search on interventions designed specifically for women
with GDM, and none in the UK to our knowledge. In
order to be able to assess the feasibility and practicality
of a lifestyle intervention targeted at women with GDM,
it is important to establish the nature of the progression
from GDM to T2D in the UK context. A systematic re-
view of studies assessing the association between GDM
and T2D did not report any research that had been con-
ducted in the United Kingdom [7]. This study therefore
characterises the progression of GDM to T2D in the
Dundee and Angus region of Scotland, UK.Methods
Study design and population
This observational study used historical routinely col-
lected health-care data to follow up women diagnosed
with GDM. Antenatal care is a universal service accessedhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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nosed with GDM during routine antenatal care in the
Dundee and Angus region (approximate population
250,000) attend the Diabetes Antenatal Clinic at Ninewells
Hospital in the city of Dundee. All women in Dundee and
Angus were screened with a fasting blood glucose (FBG)
or random blood glucose (RBG) at 28 weeks gestation. All
patients with any abnormal result (RBG of >5.5 mmol/l−1
two or more hours after food or >7.0mmo/l−1 within two
hours of food; FBG >5.5 mmol/l−1), any glycosuria and all
high risk pregnancies underwent a 75 g oral glucose toler-
ance test (OGTT). All women diagnosed with GDM who
had attended this clinic between 1994 and 2004, and who
had no previous diagnosis of Type 1 or Type 2 diabetes
were included in this study. Women diagnosed with GDM
in the first trimester of pregnancy were excluded as
these women were likely to have had undiagnosed preg-
estational diabetes [8]. GDM was diagnosed on the basis
of clinical guidance in use at the time of the study which
suggested an FBG of greater than 5.5 mmol/l−1or a
blood glucose reading two hours (2 h BG) after an
OGTT of greater than 9 mmol/l−1.
Data were extracted from paper based case records
held at Ninewells Hospital containing clinical and per-
sonal data for all women who had attended the diabetes
antenatal clinic between 1994 and 2004. These records
included the following forms: a booking form which was
completed at the first visit to the clinic after a diagnosis
of GDM; follow up forms for each further visit to the
clinic and a postnatal form containing information from
a postnatal check-up. The information extracted from
these forms included the mother’s date of birth, family
history of diabetes, history of GDM in a previous preg-
nancy, parity, birth weight of previous babies, week of
gestation, OGTT fasting and 2 hour blood glucose levels
at booking and postnatal (where recorded), mother’s
weight, Hba1C and treatment during pregnancy. Week
of gestation, mother’s weight and HbA1c were extracted
from the booking, follow up and postnatal forms where
recorded.
Data extracted from the paper based records were
anonymised and linked to SCI-DC, a validated diabetes
clinical information system [9], by the Health Informat-
ics Centre at the University of Dundee (HIC). Patients
were followed up for a diagnosis of T2D using the Scottish
Care Information – Diabetes Collaboration (SCI-DC) sys-
tem which holds complete information on patients diag-
nosed with T2D in Scotland up to March 2012. Women
who died or migrated out of the health board during the
follow up were not excluded from the study but the date
of death/migration was used as their study end date in the
analysis.
Patients with T2D are defined as those who are diag-
nosed with diabetes over the age of 35 years, or youngerpatients for whom there is no immediate requirement
for insulin. World Health Organisation (WHO) criteria
were used to diagnose T2D but the precise glucose levels
used depended upon the criteria in use at the time of
diagnosis. The majority of women included in the study
(97%) were diagnosed using the WHO criteria published
in 1999 [10] which defines T2D on the basis of a fasting
plasma venous sample of 7.0 mmol/l−1 or higher and a
2 hour post OGTT value of 11.1 mmol/l−1. The remain-
der were diagnosed using the WHO 1985 criteria [11]
which had a higher value for fasting venous plasma of
7.8 mmol/l−1 or higher but the same 2 hour value. The
data were also linked to a portion of the ISD SMR02
dataset which provided demographic information not
available from paper based records such as deprivation
category (from the Scottish Index of Multiple Deprivation
[12] and body mass index (BMI). The SIMD deprivation
category is a postcode measure derived from multiple
aspects of deprivation including employment, income,
health, education, access to services, crime and housing.
Analysis
In survival analyses, women were followed up from the
date of diagnosis of gestational diabetes. Women who
had more than one pregnancy during the study period
were followed up from the earliest date of diagnosis of
gestational diabetes. The relationships between potential
risk factors and development of T2D were assessed by
univariate and multivariate Cox regression, from which
hazard ratios (HRs) and 95% confidence intervals (CIs)
were calculated. Deprivation category, age, history of
GDM, family history of diabetes, use of insulin during
pregnancy, average weekly weight gain and weight, tri-
mester, HbA1c, FBG, 2 h BG at diagnosis of GDM were
entered as independent variables, with diagnosis of T2D
as the dependent variable. Statistical analyses were car-
ried out using SPSS for Windows version 21. Ethical ap-
proval was obtained from the School of Nursing,
Midwifery and Health at the University of Stirling. The
Tayside Committee for Medical Research Ethics has
granted approval for studies using routinely collected,
anonymised health data and this study falls under this
approval.
Results
Characteristics of population
Data were extracted from the records for 285 women, of
which 164 women met the criteria for GDM and had no
previous diagnosis of Type 1 or Type 2 diabetes, and
were therefore included in the study. Of the remainder,
75 women had Type 1 Diabetes, 12 had Type 2 Diabetes,
2 were diagnosed with GDM in the first trimester and 1
had maturity onset diabetes of the young. A further 21
women were classified as borderline GDM as their blood
Figure 1 Cumulative incidence of T2D after diagnosis of GDM.
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for GDM. Ten women with GDM were excluded due to
having missing data or a previous diagnosis of Type 1 or
Type 2 diabetes.
At the time of diagnosis of GDM, women ranged in
age from 16 to 43 with a mean age of 30. Table 1 shows
further characteristics of the population. Women were
more commonly from areas of higher deprivation than
lower deprivation. A positive family history of diabetes
was noted for around a third of women and the majority
were having their first or second child. BMI data were
not recorded for the majority of women in this study.
Progression to type 2 diabetes
Forty one women (25%) developed T2D during follow-
up. The time between diagnosis of GDM and T2D
ranged from 4 months to nearly 16 years, with a mean
time of 93 months (SD = 48.2) or nearly 8 years. Of these
women only 3 (7.3%) went on to develop T2D in the
two years after their diagnosis of GDM and a further 4
(9.8%) developed T2D two to four years after their diag-
nosis of GDM. Figure 1 shows a relatively steady rate of
T2D incidence after diagnosis of GDM over the study
period. Table 2 shows the results of both univariate and
multivariate Cox survival analysis. Greater weight during
pregnancy, insulin use during pregnancy, higher HbA1c
levels and FBG were associated with highly elevated risks
of progression to T2D in univariate and multivariate
analyses. Although 2 h BG and were also associated with
an increased risk univariately, this association was no
longer statistically significant after adjusting for otherTable 1 Characteristics of the population
Deprivation category n (%)
5 (Lowest Deprivation) 17 (10.4)
4 39 (23.8)
3 21 (12.8)
2 35 (21.3)
1 (Highest Deprivation) 44 (26.8)
Data Missing 8 (4.9)
Previous live births n (%)
0 57 (34.8)
1 54 (32.9)
2 28 (17)
3 or more 19 (11.6)
Data Missing 6 (3.7)
Mother’s weight (kg) n (%)
Up to 76.8 46 (28)
76.8-92.5 49 (29.9)
Over 92.5 53 (32.3)
Data Missing 16 (9.8)variables. While there were no statistically significant as-
sociations for increasing age, family history of T2D or
previous history of GDM, the hazard ratios were ele-
vated. There was no evidence for an association with
deprivation or average weekly weight gain.
Discussion
To the best of our knowledge this study is the first to in-
vestigate progression from GDM to T2D in the UK. We
found that around a quarter of women diagnosed with
GDM developed T2D with a mean time window be-
tween the two diagnoses of 8 years. The vast majority of
women who did develop T2D after GDM did so five
years or more after their diagnosis of GDM. This time
period presents a considerable window of opportunity to
deliver an intervention and for women to make neces-
sary changes to their diet and activity levels in order to
reduce the risk of progression to T2D. Many people find
making lifestyle changes difficult and women who have
recently had a baby face additional problems. For ex-
ample, a lack of time is often cited by women who have
had GDM as a barrier to making lifestyle changes [13].
Our findings suggest that the window of opportunity
may be large enough for the majority of women to allow
an intervention to be delayed until the child is slightly
older and less dependent. Such a delay may help to ad-
dress some of the barriers to lifestyle change faced by
women with GDM but this argument becomes complex
if women are planning to have more children. This issue
is further complicated by the fact some women have
already made lifestyle changes during pregnancy in an
attempt to manage their GDM. With these women it
may be best to intervene sooner after pregnancy to ensure
these changes are maintained. The timing of lifestyle inter-
ventions for women who have had GDM clearly needs
further exploration with women, along with the optimal
Table 2 Hazard ratio of developing T2D in patients with GDM according to previous history of GDM, family history of
diabetes, deprivation category; insulin use and average weekly weight gain during pregnancy; and weight, age,
trimester, HbA1c, fasting and 2 hour blood glucose at diagnosis of GDM
Univariate Multivariate
No. (%) progressing
to T2D
Mean time to
progress (months)
Hazard ratio
(95% CI)
p value Hazard ratio
(95% CI)
p value
Whole sample (n=164) 41 (25) 93
Deprivation category
(no. in each group)
5 least deprived (17) 2 (12) 21 1.00 1.00
4 (39) 8 (21) 78 1.44 (0.31-6.76) 0.647 0.68 (0.12-3.95) 0.671
3 (21) 6 (29) 94 1.86 (0.38-9.20) 0.448 0.71 (0.11-4.61) 0.717
2 (35) 13 (37) 115 2.81 (0.63-12.45) 0.174 1.92 (0.37-10) 0.438
1 most deprived (44) 11 (25) 82 1.76 (0.39-8.89) 0.461 0.76 (0.15-3.93) 0.742
Data missing (8) 1 (13) 106 0.81 (0.07-8.89) 0.860 0.9 (0.07-11.96) 0.936
Age (no.)
25 and under (32) 6 (19) 99 1.00 1.00
26 to 34 (84) 19 (23) 93 1.28 (0.51-3.19) 0.604 1.35(0.48-3.79) 0.570
35 and over (48) 16 (33) 86 1.90 (0.74-4.87) 0.179 2.38 (0.82-6.95) 0.112
Previous history of GDM (no.)
Yes (11) 4 (36) 83 1.7 (0.61-4.77) 0.315 2.83 (0.62-12.87) 0.179
No/Data missing (153) 37 (24) 91 1.00 1.00
Family history of diabetes (no.)
Yes (59) 17 (29) 89 0.80 (0.43-1.49) 0.485 1.42 (0.64-3.15) 0.385
No/Data missing (105) 24 (23) 93 1.00 1.00
Weight (no.)
Up to 76.8 kg (46) 3 (7) 70 1.00 1.00
76.8 to 92.5kg (49) 15 (31) 88 5.19 (1.5-17.93) 0.009 4.98 (1.23-20.18) 0.024
Over 92.5kg (53) 20 (38) 89 6.49 (1.93-21.86) 0.003 5.22 (1.38-19.73) 0.015
Data missing (16) 3 (19) 150 3.05 (0.62-15.12) 0.172 3.5 (0.53-23.34) 0.196
Trimester at diagnosis (no.)
2nd trimester (16) 5 (31) 96 1.21 (0.47-3.07) 0.696 1.05 (0.32-3.45) 0.942
3rd trimester (147) 36 (24) 90 1.00 1.00
HbA1c in mmol/mol (no.)
33.3 and under (19) 3 (16) 150 1.00 1.00
33.3 to 42.1 (22) 5 (23) 82 1.42 (0.34-5.95) 0.630 1.59 (0.29-8.84) 0.597
42.1 plus (18) 8 (44) 57 4.41 (1.17-16.69) 0.029 5.34 (0.98-29) 0.052
Data missing (105) 25 (24) 98 1.66 (0.5-5.5) 0.407 1.9 (0.45-7.94) 0.381
Fasting blood glucose in
mmol/l (no.)
Under 5.1 (52) 6 (12) 102 1.00 1.00
5.1 to 7.0 (72) 20 (28) 93 2.62 (1.05-6.53) 0.038 1.66 (0.52-5.24) 0.392
Over 7.0 (17) 6 (35) 60 6.87 (2.2-21.44) 0.001 3.94 (0.92-16.91) 0.065
Data missing (23) 9 (39) 99 3.87 (1.38-10.89) 0.010 35.29 (2.18-570.68) 0.012
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Table 2 Hazard ratio of developing T2D in patients with GDM according to previous history of GDM, family history of
diabetes, deprivation category; insulin use and average weekly weight gain during pregnancy; and weight, age,
trimester, HbA1c, fasting and 2 hour blood glucose at diagnosis of GDM (Continued)
2 hour post load blood
glucose in mmol/l (no.)
Under 8.5 (39) 7 (18) 83 1.00 1.00
8.5-11.1 (67) 14 (21) 96 1.15 (0.46-2.85) 0.762 1.54 (0.54-4.38) 0.417
Over 11.1 (36) 12 (33) 84 2.58 (1.01-6.56) 0.047 2.37 (0.76-7.4) 0.139
Data missing (22) 8 (36) 99 2.13 (0.77-5.88) 0.144 0.1 (0.01-1.56) 0.101
Used Insulin during
pregnancy (no.)
Yes (51) 20 (39) 88 2.82 (1.52-5.2) 0.001 2.81 (1.35-5.86) 0.006
No (113) 21 (19) 94 1.00 1.00
Average weekly weight
gain (kg)
0.3 and under (61) 16 (26) 82 1.00
0.31 and above (64) 14 (22) 90 0.71 (0.35-1.47) 0.360 0.61 (0.2-1.45) 0.259
Data Missing (39) 11 (28) 105 1.04 (0.49-2.25) 0.912 1.12 (0.43-2.93) 0.821
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successful.
Women who were at highest risk of developing T2D
after GDM were heavier women, those with an HbA1c
of over 42.1 mg/dL, those who used insulin during their
pregnancy and those with FBG of 7.0 mmol/l and over.
These women should arguably be prioritised for interven-
tion. These findings are largely consistent with previous
research reported in a systematic review of studies asses-
sing the incidence of T2D after a diagnosis of GDM [7].
Higher FBG levels and HbA1c were associated with
higher risk univariately, but this increased risk was only
marginally significant in the multivariate analysis. How-
ever, we identified an increased risk of four fold for
women who had an FBG of 7.0 and over five fold for
women with an HbA1c of over 42.1 mg/dL. Given the
small sample size and wide confidence intervals in this
study, these marginally significant risks cannot be dis-
counted. It is difficult to compare our finding for FBG
with previous research that has generally looked at FBG
as a continuous variable; thus particular thresholds of
FBG for increased risk of T2D have been difficult to pin-
point. Studies that did use categories for FBG reported
varying findings. One study found an 11 fold risk in
women who had an FBG of 5.9 or over compared to
those with lower FBG values [14]. Two other studies re-
ported that women who went on to develop T2D had a
mean FBG of closer to 8.0 [15,16].
The systematic review of studies assessing the inci-
dence of T2D after a diagnosis of GDM [7] reported
mixed findings for the association between BMI and fu-
ture T2D risk. There were insufficient data for BMI in
the present study to include it in the survival analysis.However, weight was found to be significantly associated
with increased risk of T2D in the multivariate analysis,
with other factors such as trimester controlled for. Al-
though weight is typically regarded as an unreliable
measure of obesity and disease risk as it does not take
into account height, our study does suggest that it may
be a useful indicator of future risk of T2D in women
with GDM.
We did not find statistically significant associations be-
tween increasing age, history of GDM in a previous preg-
nancy or family history of diabetes and future risk of T2D.
Although the hazard ratio estimates were elevated, par-
ticularly for previous history of GDM, and therefore in-
creased risks cannot be discounted, the sample size in our
study was relatively small and confidence intervals were
wide. Previous research reports mixed results for these
risk factors; therefore larger studies are required to verify
the results.
Despite being a small study, the diagnosis of GDM in
our sample of 164 women was validated for each one and
we are confident in the high quality of our data. Detailed
information was collected from paper records using a pre-
defined data collection tool. The subsequent T2D diagno-
ses were made using a diabetes clinical information system
that has been extensively used in health care research and
is known to be accurate. However, with around 2,600
births per year in Dundee and Angus, it is clear that we
did not identify all cases of GDM during the study period.
We would have expected to identify between 500 and 600
women over the period of the study using a conservative
rate of 2% of pregnancies affected by GDM. On the other
hand, we know that the women that we did include defin-
itely had GDM, even if they represent a sample only.
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GDM might include the non-universal screening of
women for GDM, ‘lost’ paper-based records, women at-
tending other diabetes antenatal clinics in the region or
women treated solely in primary care or general antenatal
clinics. It is also likely that a proportion of women who
had GDM went undiagnosed due to lower awareness of
the condition in the past. Another limitation of this study
was the high level of missing data in the paper records for
several of the variables of interest which limited our ability
to investigate them in depth. Despite these limitations, this
is the first study of its kind to be carried out in the UK.
The region in which the study was carried out is broadly
representative of the total population of Scotland and
the results are more generalizable to the UK than simi-
lar studies in Europe and the United States.
Conclusions
In summary, this study clearly shows how a diagnosis of
GDM can have an adverse impact on health that extends
long after the pregnancy. This study highlights those
women with GDM who are at the greatest risk of pro-
gressing from GDM to T2D and should therefore be
prioritised for preventative intervention and suggests
there is a viable time window to prevent progression
from GDM to T2D in the majority of women. While a
diagnosis of GDM presents an ideal opportunity for an
intervention to reduce the growing burden of T2D, iden-
tifying the most effective way and optimal time to help
women who are at a particularly busy period of their
lives to engage in lifestyle change remains a challenge
that needs further exploration.
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